Business Paid
Medinice preparing for its first commercializations
14:35
The WSE-listed company developing innovative medical devices in cardiology and cardiac surgery, Medinice, has summarized its first quarter of 2023 results, reporting revenues of PLN 60,000, which is a stable result compared to the same period in 2022.
This article is for subscribers
Warsaw Business Journal subscribers get the full archive (12,248 articles going back to 1995) and the print edition.
SubscribeOr try Poland A.M. free for 7 days, the daily briefing, or see all plans and prices.
